{"name":"Université de Lubumbashi","slug":"universit-de-lubumbashi","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Pyrethroids","genericName":"Pyrethroids","slug":"pyrethroids","indication":"Other","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"synergistic combination of insecticides","genericName":"synergistic combination of insecticides","slug":"synergistic-combination-of-insecticides","indication":"Vector-borne disease control (likely malaria, dengue, or other insect-transmitted diseases)","status":"marketed"}]}],"pipeline":[{"name":"Pyrethroids","genericName":"Pyrethroids","slug":"pyrethroids","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"synergistic combination of insecticides","genericName":"synergistic combination of insecticides","slug":"synergistic-combination-of-insecticides","phase":"marketed","mechanism":"A synergistic combination of insecticides that work together to enhance pest control efficacy through complementary modes of action.","indications":["Vector-borne disease control (likely malaria, dengue, or other insect-transmitted diseases)"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}